HIGHLIGHTS
- who: Paul Thoueille and colleagues from the of an Study in Switzerland Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland have published the article: Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland, in the Journal: (JOURNAL)
- what: None of these endpoints of the SHCS#879 study have yet been attained at this early stage of the study, and thus, this article focuses only on preliminary results indicating whether or not they support the underlying assumption on the clinical interest of TDM . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.